Trial Profile
Exercise Training and Testosterone Replacement in Heart Failure Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Heart failure; Hypogonadism
- Focus Pharmacodynamics
- 03 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2013 New trial record